Abstract
Two new organopolyphosphazenes, viz., poly[bis(3-methoxy benzyloxy) phosphazene] (POP-1) and poly[bis(4-fluoro-4′-oxybenzophenone)]phosphazene (POP-2), have been prepared by replacing chlorine atoms of dichloropolyphosphazene with 3-methoxy benzylalcohol and 4-fluoro4′- hydroxy-benzophenone. The polymers have been characterized by Fourier tranform infrared spectroscopy (FT-IR), 1H- and 31P-nuclear magnetic resonance (NMR) spectra and thermogravimetric (TGA) analyses. The polymers have been developed as microspheres to study their controlled-release characteristics for indomethacin, an anti-inflammatory drug. Drug-loaded microspheres have been tested for in vitro release in pH 7.4 buffer media. FT-IR, 1H- and 31P-NMR data confirmed the formation of polyorganophosphazenes substituted with 3-methoxy benzylalcohol and 4-fluoro-4′-hydroxy-benzophenone. In vitro drug-release studies have indicated sustained and controlled release of indomethacin through POP microspheres.
Original language | English (US) |
---|---|
Pages (from-to) | 235-251 |
Number of pages | 17 |
Journal | Designed Monomers and Polymers |
Volume | 10 |
Issue number | 3 |
DOIs | |
State | Published - 2007 |
Keywords
- Controlled release
- Microspheres
- Organopolyphosphazenes
- Spectral studies
- Synthesis
ASJC Scopus subject areas
- Chemistry(all)
- Chemical Engineering(all)
- Polymers and Plastics
- Materials Chemistry